General Information of Disease (ID: DIS5J8B5)

Disease Name Memory loss
Disease Class MB21: Cognition symptoms/signs/clinical sympton
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DIS5J8B5: Memory loss
ICD Code
ICD-11
ICD-11: MB21.1Z
Expand ICD-11
'MB21.1Z

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AC-1202 DMNVFZA Phase 2 Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
LB-101 DMXUDH7 Investigative NA [2]
LB-102 DMC366Y Investigative NA [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT00142805) Ketasyn in Mild to Moderate Alzheimer's Disease. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.